Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is first to establish what is the ideal dose of gemcitabine, a chemotherapy agent, when given in combination with radiation. In addition, the investigators want to determine the side effects and the effectiveness of this combination. The investigators will also study several markers to try to identify markers or tests that will predict which patients will benefit more from this treatment.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00184093
Study type Interventional
Source University of Southern California
Contact
Status Completed
Phase Phase 1/Phase 2
Start date June 1999
Completion date May 2009

See also
  Status Clinical Trial Phase
Terminated NCT01234480 - Intended Use Study of the BD SurePath Plus™ Pap
Completed NCT05022511 - Three Birds With One Stone N/A
Recruiting NCT04857528 - Detecting HPV DNA in Anal and Cervical Cancers
Completed NCT01755897 - A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients N/A
Recruiting NCT01667211 - Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer Phase 2
Active, not recruiting NCT01226264 - Diffusion MRI; Predictive Value for Cervical Uterine Cancer Recurrence N/A
Recruiting NCT03961191 - DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
Enrolling by invitation NCT01393470 - Evaluation of Long-term HPV Vaccine Efficacy N/A
Terminated NCT00421096 - Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer Phase 2
Terminated NCT01284348 - To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer Phase 2
Recruiting NCT03961178 - A Cohort Study for the Following up of Conization
Terminated NCT02317302 - FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer Phase 1
Not yet recruiting NCT06254846 - Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study). N/A
Not yet recruiting NCT05824494 - Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors Phase 2
Recruiting NCT03960879 - DNA Methylation for Screening Uterine Cervical Lesions
Recruiting NCT04886700 - Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer Phase 2
Completed NCT02095119 - A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer Phase 1/Phase 2
Enrolling by invitation NCT05231993 - Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening N/A
Recruiting NCT02036164 - Adjuvant Chemotherapy for Locally Advanced Cervical Cancer Phase 3
Recruiting NCT04974424 - Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV